echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Eli Lilly announced that the US government will purchase more doses of neutralizing antibody therapy to treat COVID-19

    Eli Lilly announced that the US government will purchase more doses of neutralizing antibody therapy to treat COVID-19

    • Last Update: 2021-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Eli Lilly recently announced that the US government has agreed to purchase at least 100,000 doses of 700 mg of Bamlanivimab (LY-CoV555) and 1,400 mg of etesevimab (LY-CoV016) together.


    Bamlanivimab and etesevimab have recently obtained emergency use authorization together to treat mild to moderate COVID-19 hospitalized patients.


    COVID-19 In addition, the National Institutes of Health (NIH) recently updated its COVID-19 treatment guidelines, recommending the use of bamlanivimab in combination with etesevimab to treat patients with mild to moderate COVID-19 who are at high risk of clinical progression.


    The US government stated that it will provide neutralizing antibodies to patients for free, although medical institutions may charge fees for the management of the product .


    diagnosis

     

    Original source:

    Original source:

    https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.